作者: Marc J Shapiro
DOI: 10.1186/CC2453
关键词:
摘要: The safety of the blood supply has been a concern over past 20–30 years because transmission infectious diseases. Blood is still routinely tested for viruses, and leukoreduction an effective strategy to reduce cell-associated viruses. Clinically, benefits include decreases in transfusion reactions, HLA alloimmunization, infections, fever episodes, antibiotic use. Although will add cost unit blood, projections indicate that leukoreduced become standard care.